AzTrials
AzTrials

Assisted SuicideNCT04261088

Assisted Suicide in Switzerland

An observational study of Assisted Suicide, run by National Institutes of Health Clinical Center (CC) at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Background: Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Assisted Suicide
How many people
25 participants
Where
1 siteUnited States
Study dates
3 Feb 2020to 31 Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 25 transcripts of interviews with: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1

Who may be able to join

  • The study includes 25 interviews with Swiss experts that have been conducted.
  • Gender: Men 14, Women 11
  • Backgrounds of interviewees: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1
  • Race and ethnicity: All white Swiss.
  • Age range: Unknown, but all are adults.
  • No vulnerable populations.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892

Other trials in United States

About this study

Background:

Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts.

Read more

Objective:

To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice.

Eligibility:

Swiss experts in the field of assisted suicide

Design:

The study includes 25 interviews that have already been conducted. The participants were:

  • academics
  • doctors and others in medical care
  • a government official
  • representatives of right-to-die societies.

Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.

Read the detailed description

Switzerland is the only country in the world that enables assisted suicide by lay people, i.e.,

people who are not physicians. All other countries that have adopted aid-in-dying legislation

require that a physician provides this assistance. This project probes the reasons for adopting this policy, and the advantages and the disadvantages of the Swiss model at the end of life. Are the Swiss aid-in-dying volunteers able to provide well-informed assistance to patients in need? Is the Swiss model one to be followed by other nations? The project will focus on the work of the Swiss aid-in-dying societies. The study draws on research in the fields of ethics, law and medicine. Its novelty lies in incorporating different methods of analysis, reflecting on the right to die with dignity within a liberal framework that aims to respect fundamental human rights.

Keywords
Ethics, Switzerland, End of life, Assisted Death, Natural History
Medical subject headings
Suicide, Assisted, Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04261088
Study groupRoleWhat they receive
Experts in Swiss assisted suicidePersons in Switzerland who are experts in how assisted suicide is practiced. We will beexamining already collected interviews.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Descriptive study

    This is a qualitative descriptive study of transcripts.

    Measured: Ongoing

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2020
  2. Study start3 Feb 2020
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04261088
Sponsor's protocol ID
999920059
Other IDs
20-CC-N059
Status last verified
2 Dec 2025
First submitted
6 Feb 2020
Last updated
13 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Assisted Suicide, run by National Institutes of Health Clinical Center (CC) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Descriptive study (time frame: Ongoing). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in